Notably, only the mRNA levels of MLKL and RIPK1, but not RIPK3, were significantly negatively correlated with MMSE scores in AD patients (Arevalo-Rodriguez et al., 2015). This evidence concerns the gene RIPK3 and Alzheimer disease.